Telemark Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$29.7M | – | 66 |
|
|
2024
Q2 | $29.7M | Hold |
250,000
| – | – | 2.58% | 7 |
|
|
2024
Q1 | $26.6M | Buy |
+250,000
| New | +$26.6M | 2.75% | 7 |
|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$20.7M | – | 56 |
|
|
2023
Q3 | $20.7M | Hold |
200,000
| – | – | 3.13% | 10 |
|
|
2023
Q2 | $24.3M | Buy |
200,000
+50,000
| +33% | +$6.08M | 3.3% | 13 |
|
|
2023
Q1 | $23M | Sell |
150,000
-150,000
| -50% | -$23M | 3.42% | 14 |
|
|
2022
Q4 | $53.9M | Buy |
300,000
+50,000
| +20% | +$8.98M | 8.17% | 1 |
|
|
2022
Q3 | $29.6M | Buy |
250,000
+60,000
| +32% | +$7.1M | 4.64% | 7 |
|
|
2022
Q2 | $27.1M | Sell |
190,000
-10,000
| -5% | -$1.43M | 4.59% | 5 |
|
|
2022
Q1 | $34.5M | Sell |
200,000
-50,000
| -20% | -$8.61M | 3.04% | 7 |
|
|
2021
Q4 | $63.5M | Sell |
250,000
-100,000
| -29% | -$25.4M | 4.54% | 4 |
|
|
2021
Q3 | $135M | Buy |
350,000
+50,000
| +17% | +$19.2M | 9.75% | 1 |
|
|
2021
Q2 | $70.5M | Buy |
300,000
+65,000
| +28% | +$15.3M | 5.63% | 2 |
|
|
2021
Q1 | $30.8M | Buy |
+235,000
| New | +$30.8M | 2.61% | 9 |
|